Baker McKenzie advises Buenavista on Tiryaq deal
Baker McKenzie has advised Buenavista Equity Partners on the acquisition of a 71.2% stake in Tiryaq Medical Group, a healthcare group specializing in trauma care and minimally invasive surgery. The deal combines a share acquisition with a capital increase, structured to support the company’s growth from its Madrid base into the rest of Spain, both organically and through the acquisition of complementary businesses.
The transaction gives Buenavista Equity Partners a majority stake in Tiryaq Medical Group, positioning the private equity firm to back the company’s expansion strategy across the Spanish healthcare market. The combined structure of share purchase and capital injection is designed to fund both organic growth and future bolt-on acquisitions.
The team
Baker McKenzie’s Corporate/M&A team advising on the deal was led by partner Carlos Martín, with support from Modesto Puerta, Isabel Rodríguez and Sol García.
